Invention Grant
- Patent Title: CETP inhibitors
- Patent Title (中): CETP抑制剂
-
Application No.: US12083183Application Date: 2006-10-13
-
Publication No.: US07935727B2Publication Date: 2011-05-03
- Inventor: Yi-Heng Chen , Zhijian Lu , Peter J. Sinclair
- Applicant: Yi-Heng Chen , Zhijian Lu , Peter J. Sinclair
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent Mark R. Daniel; James L. McGinnis
- International Application: PCT/US2006/040400 WO 20061013
- International Announcement: WO2007/047591 WO 20070426
- Main IPC: A01N47/10
- IPC: A01N47/10 ; A61K31/27 ; C07C331/00 ; C07C381/00 ; C07C333/00 ; C07C261/00 ; C07C269/00 ; C07C271/00
Abstract:
Compounds having a biphenyl group substituted with a phenyl or heteroaromatic group, as shown in Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis:
Public/Granted literature
- US20090124689A1 CETP Inhibitors Public/Granted day:2009-05-14
Information query
IPC分类:
